Evidence map›Paper›PMID 36460858›Full record

ReviewEye (London, England)2023

Transforming ophthalmology in the digital century-new care models with added value for patients.

Livia Faes, Peter M Maloca, Katja Hatz, Thomas J Wolfensberger, Marion R Munk, Dawn A Sim, Lucas M Bachmann, Martin K Schmid

Open access · bronzeAbstract readReview
In one paragraph

Review in Eye (London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Livia FaesMoorfields Eye Hospital, 162 City Rd, London, EC1V 2PD, UK.
Peter M MalocaMoorfields Eye Hospital NHS Foundation Trust, 162 City Road, London, EC1V 2PD, UK.
Katja HatzVista Eye Clinic Binningen, Hauptstrasse 55, CH-4102, Binningen, Switzerland.
Thomas J WolfensbergerJules Gonin Eye Hospital, University of Lausanne, Lausanne, Switzerland.
Marion R MunkOphthalmology, Inselspital, University Hospital Bern, Bern, Switzerland.
Dawn A SimMoorfields Ophthalmic Reading Centre and Artificial Intelligence Lab, Moorfields Eye Hospital NHS Foundation Trust, London, UK.
Lucas M BachmannMedignition AG, Engelstrasse 6, 8004, Zurich, Switzerland. bachmann@medignition.com.ORCID 0000-0002-9868-154X
Martin K SchmidEye Clinic, Lucerne Cantonal Hospital LUKS, 6000 16, Lucerne, Switzerland.
Moorfields Eye Hospital NHS Foundation Trust · GBHôpital Ophtalmique Jules-Gonin · CHNorthwestern University · USUniversity of Basel · CHUniversity of Lucerne · CHUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ophthalmology faces many challenges in providing effective and meaningful eye care to an ever-increasing group of people. Even health systems that have so far been able to cope with the quantitative patient increase, due to their funding and the availability of highly qualified professionals, and improvements in practice routine efficiency, will be pushed to their limits. Further pressure on care will also be caused by new active substances for the largest group of patients with AMD, the so-called dry form. Treatment availability for this so far untreated group will increase the volume of patients 2-3 times. Without the adaptation of the care structures, this quantitative and qualitative expansion in therapy will inevitably lead to an undersupply.There is increasing scientific evidence that significant efficiency gains in the care of chronic diseases can be achieved through better networking of stakeholders in the healthcare system and greater patient involvement. Digitalization can make an important contribution here. Many technological solutions have been developed in recent years and the time is now ready to exploit this potential. The exceptional setting during the SARS-CoV-2 pandemic has shown many that new technology is available safely, quickly, and effectively. The emergency has catalyzed innovation processes and shown for post-pandemic time after that we are equipped to tackle the challenges in ophthalmic healthcare - ultimately for the benefit of patients and society.

Indexed as

COVID-19OphthalmologyDelivery of Health CareHumansPatientsSARS-CoV-2

Identifiers

PMID36460858
PMCPMC9735073
OpenAlexW4311261469

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.